We would like to apprise the Journal of Clinical Oncology readership of a recent development leading to the termination of the Combined Oxaliplatin Neuropathy Prevention Trial (CONCEPT) study for ...

Cetuximab plus irinotecan for metastatic colorectal cancer (mCRC): Safety analysis of the first 400 patients in a randomized phase III trial (EPIC) ...

Five common plant foods are linked to lower dementia risk through the flavonol isorhamnetin, according to a new study.

Researchers from Tokyo Medical and Dental University (TMDU) find that the side effects caused by treating brain diseases with antisense oligonucleotides are related to altered calcium balance Tokyo, ...

Researchers from Tokyo Medical and Dental University (TMDU) find that the side effects caused by treating brain diseases with antisense oligonucleotides are related to altered calcium balance. A ...

A promising therapy for a range of brain diseases involves antisense oligonucleotides (ASOs) - specialized molecules that can modulate RNA and alter protein production - directly injected into the ...

Oxaliplatin and 5-fluorouracil (5-FU) combination is a standard treatment for metastatic colorectal cancer. It is generally well tolerated but neurotoxicity thought to be caused by oxalate, a ...

A total of 132 cancer patients treated with paclitaxel in the Oncology Unit of the Hospital Alcorcón were recruited between 2006 and 2008. The study was approved by the Internal Ethical Review ...

The term neurotoxicity refers to damage to the brain or peripheral nervous system caused by exposure to natural or man-made toxic substances. These toxins can alter the activity of the nervous system ...